Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024499
Filing Date
2021-05-06
Accepted
2021-05-06 07:03:18
Documents
86
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q epzm-10q_20210331.htm   iXBRL 10-Q 2080168
2 EX-10.1 epzm-ex101_9.htm EX-10.1 46175
3 EX-10.2 epzm-ex102_114.htm EX-10.2 39551
4 EX-31.1 epzm-ex311_8.htm EX-31.1 8515
5 EX-31.2 epzm-ex312_6.htm EX-31.2 8500
6 EX-32.1 epzm-ex321_7.htm EX-32.1 6301
  Complete submission text file 0001564590-21-024499.txt   9156734

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA epzm-20210331.xsd EX-101.SCH 73621
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20210331_cal.xml EX-101.CAL 59658
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20210331_def.xml EX-101.DEF 249934
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20210331_lab.xml EX-101.LAB 545941
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20210331_pre.xml EX-101.PRE 422905
12 EXTRACTED XBRL INSTANCE DOCUMENT epzm-10q_20210331_htm.xml XML 1729353
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

EIN.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 21895717
SIC: 2834 Pharmaceutical Preparations